Therapy Areas: Central Nervous System
15 November 2018 - Biotechnology company REGENXBIO Inc (Nasdaq:RGNX) reported on Wednesday the receipt of the US Food and Drug Administration's (FDA) orphan drug designation for the one-time trea...
15 November 2018 - Saniona AB (STO:SANION) reported on Wednesday net profit of SEK15.3m, or diluted EPS of SEK0.68, for the third quarter of 2018, from July 2018 to September 2018.This was an improvem...
13 November 2018 - - US-based biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has priced an offering of USD 210m aggregate principal amount of its 6.25% convertible senior notes due 2023 in a pr...
12 November 2018 - - US-based biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCB) has selected contract research organisation Medpace, Inc. to conduct PharmaCyte's clinical trial in...
9 November 2018 - - The first patient has been enrolled in a Phase 1 investigator-initiated clinical trial of tinostamustine, an investigational treatment, in patients with newly-diagnosed unmethylate...
9 November 2018 - Saniona AB (STO:SANION), a biotechnology company within ion-channel research, announced on Thursday the entering into a one -year option agreement with biotechnology company Initiato...
Related Headlines